Therapeutic targeting of NAMPT and its associated pathways in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) remains a global health challenge that affects more than 700,000 people yearly and has a devastating five-year survival rate at <20%. Current standard of care treatment for HCC showed limited efficacy in patients, driving the need for a more effective targeted thera...
Saved in:
Main Author: | Yeo, Joanna Zhen Zhen |
---|---|
Other Authors: | - |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/160936 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma : current status and future prospects
by: Tan, Yi Lin Jane, et al.
Published: (2015) -
Targeted polymeric therapeutic nanoparticles: Design and interactions with hepatocellular carcinoma
by: Wang, Qi, et al.
Published: (2016) -
Polo-like kinase 1 in Hepatocellular Carcinoma: Clinical significance and its potential as a therapeutic target
by: MOK WEI CHUEN
Published: (2011) -
[188Re(CO)3]-chelates as therapeutic radiopharmaceuticals: Targeting hepatocellular carcinoma
by: MAUNG MAUNG SAW
Published: (2011) -
Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma
by: Mok, W.C., et al.
Published: (2014)